Budesonide Delayed Release Capsules 1
Budesonide Capsule, Delayed Release
Product Images NDC 65162-778
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 65162-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Budesonide Delayed Release Capsules 2
This is a description of a medication with the NDC code of 65162-778-30. It is a delayed-release capsule that contains 3mg of Budesonide, which is a type of medication used to treat asthma and Crohn's disease. It is recommended to take 3 of these capsules every morning and to refer to the package insert for further instructions. The capsules should be stored at room temperature, between 20°C to 25°C, and in a tight container. This medication is for prescription use only and distributed by Amneal Pharmaceuticals LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
